General Information of the Compound
Compound ID
CP0446306
Compound Name
4-(2-benzyl-1,3,4,5-tetrahydro-2-benzazepin-7-yl)morpholine
    Show/Hide
Structure
Formula
C21H26N2O
Molecular Weight
322.452
Canonical SMILES
C(N1CCCc2cc(ccc2C1)N1CCOCC1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C21H26N2O/c1-2-5-18(6-3-1)16-22-10-4-7-19-15-21(9-8-20(19)17-22)23-11-13-24-14-12-23/h1-3,5-6,8-9,15H,4,7,10-14,16-17H2
    Show/Hide
InChIKey
NPCZXDLYWNNYFY-UHFFFAOYSA-N
Physicochemical Property
logP
3.4716
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
15.71
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 132075203
ChEMBL ID
CHEMBL4175187
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04903, Sigma intracellular receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000868 PC12 Rattus norvegicus (Rat)  1
1
Ki = 81 nM
   TI
   LI
   LO
   TS